Analysts estimate that DarioHealth will report an earnings per share (EPS) of $-0.14.
Anticipation surrounds DarioHealth's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Performance in Previous Earnings
Last quarter the company missed EPS by $0.07, which was followed by a 0.76% drop in the share price the next day.
Here's a look at DarioHealth's past performance and the resulting price change:
Quarter
Q1 2025
Q4 2024
Q3 2024
Q2 2024
EPS Estimate
-0.05
-0.14
-0.27
-0.55
EPS Actual
-0.12
-0.04
-0.18
-0.20
Price Change %
-1.0%
-7.000000000000001%
-5.0%
-5.0%
Market Performance of DarioHealth's Stock
Shares of DarioHealth were trading at $0.5398 as of August 08. Over the last 52-week period, shares are down 44.09%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
Analyst Views on DarioHealth
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on DarioHealth.
Analysts have provided DarioHealth with 1 ratings, resulting in a consensus rating of Buy. The average one-year price target ...
